NO329806B1 - Pyranonforbindelser, sammensetning, anvendelse samt fremgangsmate for in vitro inhibering av ATM - Google Patents

Pyranonforbindelser, sammensetning, anvendelse samt fremgangsmate for in vitro inhibering av ATM Download PDF

Info

Publication number
NO329806B1
NO329806B1 NO20044063A NO20044063A NO329806B1 NO 329806 B1 NO329806 B1 NO 329806B1 NO 20044063 A NO20044063 A NO 20044063A NO 20044063 A NO20044063 A NO 20044063A NO 329806 B1 NO329806 B1 NO 329806B1
Authority
NO
Norway
Prior art keywords
mmol
group
compound
ring
acid
Prior art date
Application number
NO20044063A
Other languages
English (en)
Norwegian (no)
Other versions
NO20044063L (no
Inventor
Ian Timothy William Matthews
Keith Allan Menear
Niall Morrison Barr Martin
Graeme Cameron Murray Smith
Roger John Griffin
Stephan Philip Jackson
Mark James Nor
Alan Yin Kai Lau
Xiao-Ling Fan Cockcroft
Laurent Jean Martin Rigoreau
Marc Geoffrey Hummersone
Original Assignee
Kudos Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0204350.3A external-priority patent/GB0204350D0/en
Application filed by Kudos Pharm Ltd filed Critical Kudos Pharm Ltd
Publication of NO20044063L publication Critical patent/NO20044063L/no
Publication of NO329806B1 publication Critical patent/NO329806B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • AIDS & HIV (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20044063A 2002-02-25 2004-09-24 Pyranonforbindelser, sammensetning, anvendelse samt fremgangsmate for in vitro inhibering av ATM NO329806B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0204350.3A GB0204350D0 (en) 2002-02-25 2002-02-25 ATM inhibitors
US39588402P 2002-07-15 2002-07-15
PCT/GB2003/000770 WO2003070726A1 (en) 2002-02-25 2003-02-24 Pyranones useful as atm inhibitors

Publications (2)

Publication Number Publication Date
NO20044063L NO20044063L (no) 2004-09-24
NO329806B1 true NO329806B1 (no) 2010-12-20

Family

ID=27758841

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20044063A NO329806B1 (no) 2002-02-25 2004-09-24 Pyranonforbindelser, sammensetning, anvendelse samt fremgangsmate for in vitro inhibering av ATM

Country Status (19)

Country Link
EP (2) EP2174939A1 (de)
JP (1) JP2005521689A (de)
CN (1) CN100358891C (de)
AT (1) ATE451365T1 (de)
AU (1) AU2003209990B8 (de)
BR (1) BR0307944A (de)
CA (1) CA2473100A1 (de)
CY (1) CY1109835T1 (de)
DE (1) DE60330442D1 (de)
DK (1) DK1485377T5 (de)
ES (1) ES2336206T3 (de)
GB (1) GB2401606B (de)
MX (1) MXPA04007809A (de)
NO (1) NO329806B1 (de)
NZ (1) NZ534821A (de)
PL (1) PL370074A1 (de)
PT (1) PT1485377E (de)
SI (1) SI1485377T1 (de)
WO (1) WO2003070726A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7151102B2 (en) 2000-10-30 2006-12-19 Kudos Pharmaceuticals Limited Phthalazinone derivatives
GB0119863D0 (en) 2001-08-14 2001-10-10 Cancer Res Campaign Tech DNA-PK inhibitors
GB0119865D0 (en) 2001-08-14 2001-10-10 Cancer Res Campaign Tech DNA-PK inhibitors
DE60335359D1 (de) 2002-04-30 2011-01-27 Kudos Pharm Ltd Phthalazinonderivate
US7122189B2 (en) * 2002-08-13 2006-10-17 Enzon, Inc. Releasable polymeric conjugates based on aliphatic biodegradable linkers
US7413738B2 (en) 2002-08-13 2008-08-19 Enzon Pharmaceuticals, Inc. Releasable polymeric conjugates based on biodegradable linkers
GB0305681D0 (en) 2003-03-12 2003-04-16 Kudos Pharm Ltd Phthalazinone derivatives
US7449464B2 (en) 2003-03-12 2008-11-11 Kudos Pharmaceuticals Limited Phthalazinone derivatives
US20070099186A1 (en) * 2003-05-01 2007-05-03 D Adda Di Fagagna Fabrizio Methods and means for the treatment of disorders associated with cellular senescence
AU2004265149A1 (en) 2003-08-13 2005-02-24 Kudos Pharmaceuticals Limited Aminopyrones and their use as ATM inhibitors
PL2305221T3 (pl) 2003-12-01 2015-11-30 Kudos Pharm Ltd Inhibitory naprawy uszkodzeń DNA w leczeniu raka
WO2005118543A1 (ja) * 2004-06-03 2005-12-15 Ono Pharmaceutical Co., Ltd. キナーゼ阻害薬およびその用途
GB0419072D0 (en) 2004-08-26 2004-09-29 Kudos Pharm Ltd Phthalazinone derivatives
BRPI0515498A (pt) 2004-09-20 2008-07-29 Kudos Pharm Ltd inibidores de dna-pk
EP1848712A1 (de) * 2005-02-09 2007-10-31 Kudos Pharmaceuticals Ltd Atm-inhibitoren
AR053358A1 (es) 2005-04-15 2007-05-02 Cancer Rec Tech Ltd Inhibidores de adn - pk
US20070049588A1 (en) * 2005-08-31 2007-03-01 Kudos Pharmaceuticals Limited Atm inhibitor
GB0521373D0 (en) 2005-10-20 2005-11-30 Kudos Pharm Ltd Pthalazinone derivatives
MX2010002749A (es) 2007-09-14 2010-06-25 Astrazeneca Ab Derivados de ftalazinona.
CA2737400C (en) 2008-10-07 2016-11-22 Astrazeneca Uk Limited Pharmaceutical formulation 514
EP2486923B1 (de) * 2011-02-11 2015-09-09 Dr. Felix Jäger und Dr. Stefan Drinkuth Laborgemeinschaft OHG Histon-Deacetylase (HDAC) hemmende Verbindungen und Verfahren zu deren Herstellung
WO2013003112A1 (en) 2011-06-27 2013-01-03 The Jackson Laboratory Methods and compositions for treatment of cancer and autoimmune disease
JP6074043B2 (ja) * 2013-08-29 2017-02-01 富士フイルム株式会社 新規なモルホリン誘導体またはその塩
US20230256110A1 (en) 2020-06-24 2023-08-17 Astrazeneca Uk Limited Combination of antibody-drug conjugate and atm inhibitor
CN112094210A (zh) * 2020-09-24 2020-12-18 江苏扬农化工股份有限公司 一种取代的亚磺酸盐的制备方法
JPWO2024214685A1 (de) 2023-04-10 2024-10-17

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4282155A (en) * 1980-02-04 1981-08-04 Merck & Co., Inc. Antihypercholesterolemic compounds
DE68914495T2 (de) * 1988-03-02 1994-10-27 Merck & Co Inc Antihypercholesterolemisches Mittel.
ATE128128T1 (de) * 1990-06-29 1995-10-15 Upjohn Co Antiatherosclerotische und antithrombotische 2- amino-6-phenyl-4h-pyran-4-one.
IL129871A (en) * 1994-05-06 2003-11-23 Pharmacia & Upjohn Inc Process for preparing 4-phenyl-substituted octanoyl-oxazolidin-2-one intermediates that are useful for preparing pyran-2-ones useful for treating retroviral infections
WO1997043434A1 (en) * 1996-05-14 1997-11-20 Snow Brand Milk Products Co., Ltd. Novel physiologically active substance and process for producing the same
FR2765579A1 (fr) * 1997-07-01 1999-01-08 Lipha Nouveaux derives de 4-hydroxy-2h-1-(thio)pyran-2-ones leurs preparations et leurs utilisations comme rodonticides
CN1205198C (zh) * 1997-09-26 2005-06-08 东丽株式会社 环酮衍生物及其医药用途
HUP0101381A3 (en) * 1998-03-12 2002-06-28 Microbial Chem Res Found Benzofurylpyrone derivatives and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
JP2005521689A (ja) 2005-07-21
EP1485377B1 (de) 2009-12-09
DK1485377T3 (da) 2010-04-19
CA2473100A1 (en) 2003-08-28
CN1639154A (zh) 2005-07-13
CN100358891C (zh) 2008-01-02
EP1485377A1 (de) 2004-12-15
ES2336206T3 (es) 2010-04-09
SI1485377T1 (sl) 2010-04-30
PL370074A1 (en) 2005-05-16
ATE451365T1 (de) 2009-12-15
EP1485377B8 (de) 2010-02-24
GB0419534D0 (en) 2004-10-06
MXPA04007809A (es) 2004-10-15
EP2174939A1 (de) 2010-04-14
EP1485377B9 (de) 2010-10-06
AU2003209990A1 (en) 2003-09-09
GB2401606B (en) 2005-08-31
ES2336206T9 (es) 2011-03-24
AU2003209990B8 (en) 2008-10-30
WO2003070726A1 (en) 2003-08-28
CY1109835T1 (el) 2014-09-10
AU2003209990B2 (en) 2008-10-09
NO20044063L (no) 2004-09-24
HK1069827A1 (zh) 2005-06-03
DE60330442D1 (de) 2010-01-21
GB2401606A (en) 2004-11-17
NZ534821A (en) 2006-07-28
DK1485377T5 (da) 2010-12-06
BR0307944A (pt) 2005-02-01
PT1485377E (pt) 2010-03-12

Similar Documents

Publication Publication Date Title
NO329806B1 (no) Pyranonforbindelser, sammensetning, anvendelse samt fremgangsmate for in vitro inhibering av ATM
EP1417196B1 (de) Dna-pk-inhibitoren
US20090043091A1 (en) Atm inhibitors
US7642254B2 (en) ATM inhibitors
AU2005286329A1 (en) DNA-PK inhibitors
US7049313B2 (en) ATM inhibitors
EP1416936B1 (de) Thiopyran-4-one als inhibitoren der dna protein kinase
KR100977025B1 (ko) Ａｔｍ 저해제로 유용한 피라논
HK1097273B (en) Aminopyrones and their use as atm inhibitors

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees